Deciphera Pharmaceuticals, Inc. (DCPH): Price and Financial Metrics

Deciphera Pharmaceuticals, Inc. (DCPH): $25.59

0.02 (+0.08%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add DCPH to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#30 of 356

in industry

DCPH Price/Volume Stats

Current price $25.59 52-week high $25.61
Prev. close $25.57 52-week low $9.90
Day low $25.56 Volume 1,596,000
Day high $25.61 Avg. volume 1,292,551
50-day MA $21.27 Dividend yield N/A
200-day MA $15.80 Market Cap 2.21B

DCPH Stock Price Chart Interactive Chart >


Deciphera Pharmaceuticals, Inc. (DCPH) Company Bio


Deciphera Pharmaceuticals LLC develops and manufactures kinase inhibitor treatments for cancer by cutting off the ability of tumor cells to thrive and spread. Its product pipeline includes Altiratinib (DCC-2701), a MET/TIE2/VEGFR2/TRK kinase inhibitor; DCC-2618, a pan-KIT inhibitor; Rebastinib, a TIE2/VEGFR1 kinase inhibitor; and LY3009120 (DP-4978), a pan-RAF inhibitor. The company was founded in 2003 and is based in Waltham, Massachusetts.


DCPH Latest News Stream


Event/Time News Detail
Loading, please wait...

DCPH Latest Social Stream


Loading social stream, please wait...

View Full DCPH Social Stream

DCPH Price Returns

1-mo N/A
3-mo N/A
6-mo 0.31%
1-year 110.96%
3-year 195.50%
5-year 116.68%
YTD 58.65%
2023 -1.59%
2022 67.76%
2021 -31.52%
2020 -8.31%
2019 196.52%

Continue Researching DCPH

Want to see what other sources are saying about Deciphera Pharmaceuticals Inc's financials and stock price? Try the links below:

Deciphera Pharmaceuticals Inc (DCPH) Stock Price | Nasdaq
Deciphera Pharmaceuticals Inc (DCPH) Stock Quote, History and News - Yahoo Finance
Deciphera Pharmaceuticals Inc (DCPH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!